Indonesia vs Uruguay: HIV-positive TB patients on ART (antiretroviral therapy)
Indonesia
54.0%
in 2024
Uruguay
39.0%
in 2024
Indonesia rank
138th
Uruguay rank
140th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Indonesia
- Uruguay
How they compare
Indonesia currently reports 54.0% against 39.0% in Uruguay, a difference of 15.0%.
That makes Indonesia's figure about 1.4 times Uruguay's.
The two have swapped places 4 times across 16 shared years of data; in 2009 it was Indonesia ahead.
Indonesia ranks 138th and Uruguay ranks 140th of 144 countries.
Across the 3 decades both report, Indonesia averaged higher in 2 and Uruguay in 1.
Head to head by decade
| Decade | Indonesia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 19.0% | 23.0% | Indonesia |
| 2010s | 36.4% | 51.1% | 14.7% | Uruguay |
| 2020s | 39.8% | 37.6% | 2.2% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Indonesia or Uruguay?
- Indonesia, at 54.0% against 39.0% in Uruguay as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Indonesia and Uruguay?
- 15.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Uruguay?
- 16 years are reported by both, from 2009 to 2024.
- How do Indonesia and Uruguay rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Indonesia ranks 138th and Uruguay ranks 140th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.